Colonial Trust Advisors Eli Lilly & CO Transaction History

Colonial Trust Advisors

$1.14 Billion
Q3 2024

A detailed history of Colonial Trust Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Colonial Trust Advisors holds 37,780 shares of LLY stock, worth $30.1 Million. This represents 2.93% of its overall portfolio holdings.

Number of Shares

37,780

Previous 36,982 2.16%

Holding current value

$30.1 Million

Previous $33.5 Million 0.04%

% of portfolio

2.93%

Previous 3.23%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $616,167 - $766,095	798 Added 2.16%	37,780 $33.5 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $1.34 Million - $1.69 Million	-1,854 Reduced 4.77%	36,982 $33.5 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $483,827 - $647,292	-817 Reduced 2.06%	38,836 $30.2 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.71 Million - $2.01 Million	-3,254 Reduced 7.58%	39,653 $23.1 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.44 Million - $1.98 Million	-3,306 Reduced 7.15%	42,907 $23 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $618,354 - $826,811	-1,763 Reduced 3.67%	46,213 $21.7 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $577,150 - $677,835	-1,858 Reduced 3.73%	47,976 $16.5 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $114,793 - $133,757	-357 Reduced 0.71%	49,834 $18.2 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $172,847 - $196,978	583 Added 1.18%	50,191 $16.2 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $286,255 - $336,106	-1,027 Reduced 2.03%	49,608 $16.1 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $100,916 - $125,413	-430 Reduced 0.84%	50,635 $14.5 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $299,949 - $372,239	-1,334 Reduced 2.55%	51,065 $14.1 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $108,584 - $133,627	-490 Reduced 0.93%	52,399 $12.1 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $28,526 - $36,899	-158 Reduced 0.3%	52,889 $12.1 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $322,724 - $417,782	-1,964 Reduced 3.57%	53,047 $9.91 Million
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $209,779 - $277,589	1,608 Added 3.01%	55,011 $9.29 Million
Q3 2020 Oct 26, 2020	SELL	$146.22 - $169.13 $24,711 - $28,582	-169 Reduced 0.32%	53,403 $7.91 Million
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $98,358 - $118,373	721 Added 1.36%	53,572 $8.8 Million
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $174,646 - $216,162	1,467 Added 2.85%	52,851 $7.33 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $34,642 - $42,907	-324 Reduced 0.63%	51,384 $6.75 Million
Q3 2019 Nov 15, 2019	BUY	$106.79 - $116.16 $85,111 - $92,579	797 Added 1.57%	51,708 $5.78 Million
Q2 2019 Aug 21, 2019	BUY	$110.79 - $129.32 $2,880 - $3,362	26 Added 0.05%	50,911 $5.64 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $590,388 - $694,930	5,304 Added 11.64%	50,885 $6.6 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $403,796 - $452,374	-3,813 Reduced 7.72%	45,581 $5.28 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $6,353 - $7,940	74 Added 0.15%	49,394 $5.3 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $60,787 - $69,764	803 Added 1.66%	49,320 $4.21 Million
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $1.26 Million - $1.48 Million	-16,950 Reduced 25.89%	48,517 $3.75 Million
Q4 2017 Feb 21, 2018	BUY	$81.94 - $87.89 $1.39 Million - $1.49 Million	16,973 Added 35.0%	65,467 $5.53 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $70,364 - $78,098	-913 Reduced 1.85%	48,494 $4.15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	49,407	49,407 $4.07 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.

Account

Colonial Trust Advisors Eli Lilly & CO Transaction History